Plunkett Research Online: Arno Therapeutics, Inc.

ARNO THERAPEUTICS, INC. (ARNI:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Arno Therapeutics Inc is engaged in developing drug candidates to treat patients with cancer and other life threatening diseases. The Company's product candidates include Onapristone, AR-42, and AR-12......



Arno Therapeutics, Inc.
Ticker: ARNI
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 862 703-7170
Fax: 1 973 227-5759
Address: 200 Route 31 North
Suite 104
Flemington, NJ 08822 United States

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Glenn MattesCEO/Director/President
Arie BelldegrunChairman of the Board/Director
See More
Arno Therapeutics Inc is engaged in developing drug candidates to treat patients with cancer and other life threatening diseases. The Company's product candidates include Onapristone, AR-42, and AR-12......See More See More

Auditor: Crowe Horwath LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201520142013201220112010
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: